Story perspectives

Trump Finalizes Medicaid Ban on Minors’ Gender-Affirming Care

8/17/2026

Center

Trump Bans Care

U.S. President Donald Trump’s administration finalized a rule barring Medicaid and Children’s Health Insurance Program funds from covering gender-affirming care for minors, effective October 13, 2026.
The announcement came via Truth Social, with Trump directing CMS administrator Dr. Mehmet Oz to implement the rule.
Approximately 130,000 transgender minors are affected, and states may voluntarily fund the care.
Medicaid still covers mental-health services, but ends hormone treatments and surgeries, phasing out starting April 2027.

Left

Trump Bans Care

U.S. President Donald Trump’s administration finalized a rule barring Medicaid and CHIP funds from covering gender-affirming care for minors, effective October 13, 2026.
It places the greatest burden on low-income transgender youth reliant on Medicaid and CHIP, which advocates decry as terrorizing them.
Nearly 35,000 public comments were submitted, about 90 % opposing the rule.
Federal employees and families filed a class-action suit, and states have 60 days to respond.

History

Historical Context

In 2016 the Obama administration’s HHS issued Section 1557 guidance under the ACA, requiring Medicaid in 30 states to cover hormone therapy for about 12,000 beneficiaries. The Trump administration’s rule reverses that policy, denying Medicaid and CHIP funds to an estimated 130,000 transgender minors, reviving legal battles such as the 2018 Bostock v. Clayton County decision.

1 of 3

Trump Bans Care

U.S. President Donald Trump’s administration finalized a rule barring Medicaid and Children’s Health Insurance Program funds from covering gender-affirming care for minors, effective October 13, 2026.
The announcement came via Truth Social, with Trump directing CMS administrator Dr. Mehmet Oz to implement the rule.
Approximately 130,000 transgender minors are affected, and states may voluntarily fund the care.
Medicaid still covers mental-health services, but ends hormone treatments and surgeries, phasing out starting April 2027.

1 / 3